These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
246 related items for PubMed ID: 14265166
1. [THE POSSIBILITIES OF ELECTRON THERAPY IN CASE OF PHARYNGO-LARYNGEAL RECURRENCES AFTER CONVENTIONAL RADIOTHERAPY OR TELECOBALT THERAPY]. VERAGUTH P. J Radiol Electrol Med Nucl; 1964 Dec; 45():868-72. PubMed ID: 14265166 [No Abstract] [Full Text] [Related]
2. [THE SPATIAL DOSAGE DISTRIBUTION IN THE LARYNGEAL REGION IN PENDULUM IRRADIATION WITH TELECOBALT]. FRANKE HD. Strahlentherapie; 1965 Jan; 126():14-26. PubMed ID: 14266126 [No Abstract] [Full Text] [Related]
3. [TELECOBALT THERAPY OF TUMORS OF THE LARYNX AND HYPOPHARYNX. EXPERIENCES AND RESULTS OF THERAPY]. KUTTIG H. Strahlentherapie; 1963 Dec; 122():493-500. PubMed ID: 14101764 [No Abstract] [Full Text] [Related]
4. [CONVERGING ROENTGEN THERAPY AND TELECOBALT THERAPY IN THE TREATMENT OF LARYNGEAL AND HYPOPHARNGEAL NEOPLASMS]. BANFI A, COOPMANSDEYOLDI G. Radiobiol Radioter Fis Med; 1965 Dec; 20():187-210. PubMed ID: 14348431 [No Abstract] [Full Text] [Related]
7. [TELECOBALT THERAPY OF MALIGNANT TUMORS IN THE AREA OF THE HEAD AND NECK]. YADURA F, ZAMECNIK J. Radiobiol Radiother (Berl); 1964 Dec; 5():285-8. PubMed ID: 14190198 [No Abstract] [Full Text] [Related]
9. [THE EFFECT OF TELECOBALT IRRADIATION ON THE REGIONAL LYMPHATIC SYSTEM IN MALIGNANT TUMORS IN THE LARYNGOPHARYNGEAL REGION]. KLEY W. Arch Ohren Nasen Kehlkopfheilkd; 1963 Dec 09; 182():399-403. PubMed ID: 14116973 [No Abstract] [Full Text] [Related]
11. [CLINICAL TRIALS OF A METHYLHYDRAZINE DERIVATIVE AND ITS COMBINATION WITH TELECOBALT THERAPY]. JACOB P, ABATUCCI JS, VIALLANEIX JP. J Belge Radiol; 1964 Dec 09; 47():896-905. PubMed ID: 14262755 [No Abstract] [Full Text] [Related]
12. COMBINED RADIATION AND SURGICAL THERAPY FOR CANCER OF THE LARYNX AND LARYNGOPHARYNX. II. GOLDMAN JL, SILVERSTONE SM, ROSIN HD, CHEREN RV, ZAK FG. Trans Am Laryngol Rhinol Otol Soc; 1964 Dec 09; ():602-25. PubMed ID: 14270869 [No Abstract] [Full Text] [Related]
13. [INFLUENCE OF DOSE AND EXPOSURE ON THE SURVIVAL OF A GROUP OF LARYNGEAL CANCER PATIENTS TREATED BY TELECOBALT THERAPY]. CLEMENT R, AMALRIC R, SANTAMARIA F, COLONNADISTRIA J. J Radiol Electrol Med Nucl; 1964 Dec 09; 45():859-60. PubMed ID: 14269629 [No Abstract] [Full Text] [Related]
15. [TELECOBALT THERAPY OF EPITHELIOMAS OF THE LARYNGEAL VESTIBULE]. ENNUYER A, BATAUINI P. Ann Otolaryngol Chir Cervicofac; 1964 Dec 09; 81():747-54. PubMed ID: 14268814 [No Abstract] [Full Text] [Related]
16. [TELECOBALT THERAPY OF CANCERS OF THE PYRIFORM SINUS]. LALANNE CM. J Radiol Electrol Med Nucl; 1964 Dec 09; 45():863-5. PubMed ID: 14265164 [No Abstract] [Full Text] [Related]
18. TREATMENT OF SUPRA-GLOTTIC CARCINOMAS BY TELECOBALT THERAPY. ENNUYER A, BATAINI P. Br J Radiol; 1965 Sep 09; 38():661-6. PubMed ID: 14331602 [No Abstract] [Full Text] [Related]
19. [TELECOBALT THERAPY IN CANCER OF THE ESOPHAGUS. TECHNIC AND IMMEDIATE RESULTS]. FERREIROSESPINOSA C. Acta Iber Radiol Cancerol; 1965 Sep 09; 20():29-60. PubMed ID: 14305933 [No Abstract] [Full Text] [Related]